| |||||||||
Former Names B6.129S4-Dgattm1Far (Changed: 15-DEC-04 ) Type Congenic; Mutant Strain; Targeted Mutation; Additional information on Genetically Engineered Mutant Mice. Species laboratory mouse Generation N10F?+4+N1p (10-OCT-04) Donating Investigator Bob Farese, Gladstone Inst of Cardiovascular Disease Description
Mice homozygous for the Dgat1tm1Far targeted mutation are viable, fertile, normal in size and do not display any gross physical or behavioral abnormalities however, homozygous mutant females exhibit a complete absence of milk production, necessitating the use of foster mothers. Dgat1 mRNA is undetectable by Northern blot analysis, and DGAT enzyme activity in a variety of tissues is either absent or shows only residual levels. Surprisingly, in DGAT deficient mice triglyceride levels and fasting serum triglycerides levels are similar to wildtype controls. Although homozygotes do not differ in body weight compared to age- and sex-matched controls, total fat pad weight is reduced. Tissue triglyceride levels are reduced 30-40% in white adipose tissue and muscle. Liver triglyceride levels tend to be lower in chow-fed DGAT-deficient mice, but high-fat feeding leads to significantly lower liver triglycerides. Changes in tissue triglyceride levels are associated with increased sensitivity to insulin and leptin. Additionally, infusion of leptin suppresses weight gain significantly more in DGAT-deficient mice compared to controls. Dry fur and hair loss in mutant mice are evident by 6-8 weeks, resulting from sebaceous gland atrophy and abnormal fur lipid production (especially type 2 wax diesters). DGAT-deficient mice also exhibit impaired water repulsion and hypothermia after water immersion. Interestingly, leptin modulates the fur and skin effects seen with DGAT deficiency. Homozygotes that are maintained on a high fat diet (21% fat by weight) are resistant to obesity. Resistance to diet-induced obesity is attributed to increased energy expenditure in Dgat1-null mice. This mutant strain is a suitable tool for use in studies examining mechanisms of triglyceride synthesis and the relationship between triglyceride synthesis and obesity, leptin, and insulin resistance. DGAT-deficient mice also provide a useful model to study the role of DGAT in fur and sebaceous gland physiology.Development
A targeting vector containing a neomycin resistance gene was used to disrupt a portion of the Dgat1 gene that enocdes the carboxy-terminal 27% of the protein product. The construct was transfected into 129S4/SvJae derived RF8 embryonic stem (ES) cells. Correctly targeted ES cells were injected into C57BL/6J blastocysts. The resulting chimeric animals were backcrossed to C57BL/6J mice.
| Control | ||
|---|---|---|
| Wild-type from the colony | ||
| 000664 C57BL/6J | ||
| Considerations for Choosing Controls | ||
Congenic Nomenclature
View Mammalian Phenotype Terms
Mammalian Phenotype Terms
assigned by genotype
The following phenotype information may relate to a genetic background differing from this JAX® Mice strain.
Dgat1tm1Far/Dgat1tm1Far
involves: 129S4/SvJae * C57BL/6J
- homeostasis/metabolism phenotype
- decreased cholesterol level (MGI Ref ID J:111346)
- after receiving a high-fat diet for 20 weeks, hepatic cholesterol ester levels are markedly reduced vs controls
- decreased circulating glucose level (MGI Ref ID J:111346)
- after high-fat diet for 8 weeks, mice have decreased blood glucose after an overnight fast vs controls
- decreased circulating leptin level (MGI Ref ID J:111346)
- serum leptin levels are significantly lower than in Dgat1-sufficient animals regardless of Adipoq genotype (4.2 ng/ml vs ~17.7 ng/ml in Dgat1-suffcient)
- decreased triglyceride level (MGI Ref ID J:111346)
- after receiving a high-fat diet for 20 weeks, hepatic triglyceride levels are markedly reduced vs controls
- improved glucose tolerance (MGI Ref ID J:111346)
- after glucose challenge, improved glucose tolerance compared to wild-type controls is seen; Dgat1-deficiency improves glucose tolerance by ~30-35% vs controls
- increased insulin sensitivity (MGI Ref ID J:61885)
- tended to have lower glucose and insulin levels after a glucose tolerance test
- increased oxygen consumption (MGI Ref ID J:111346)
- mice fed a higher fat diet have higher levels of oxygen consumption than Dgat1-sufficient mice
- increased resistance to diet-induced obesity (MGI Ref ID J:61885)
- when fed a high-fat diet, mutant mice were resistant to obesity
- mice fed a chow diet had similar body weights, but the weight of the total fat pads in mutant mice was lower than control
- mutant mice has higher metabolic rates both on a chow diet and on a high-fat diet
- behavior/neurological phenotype
- hyperactivity (MGI Ref ID J:61885)
- on the high-fat diet, mutant mice were twice as active as wild-type mice
- endocrine/exocrine gland phenotype
- abnormal lactation (MGI Ref ID J:61885)
- females had a complete absence of milk production
- reproductive system phenotype
- abnormal lactation (MGI Ref ID J:61885)
- females had a complete absence of milk production
- adipose tissue phenotype
- decreased percent body fat (MGI Ref ID J:111346)
- lower than Dgat1-sufficient mice
- growth/size phenotype
- decreased body weight (MGI Ref ID J:111346)
- when Dgat1-deficient, Adipoq-sufficient mice are weaned onto a high-fat diet, they show decreased body weight over 20 weeks vs wild-type controls
- increased resistance to diet-induced obesity (MGI Ref ID J:61885)
- when fed a high-fat diet, mutant mice were resistant to obesity
- mice fed a chow diet had similar body weights, but the weight of the total fat pads in mutant mice was lower than control
- mutant mice has higher metabolic rates both on a chow diet and on a high-fat diet
- liver/biliary system phenotype
- increased resistance to hepatic steatosis (MGI Ref ID J:111346)
- when fed a high fat diet for 20 weeks, mice show significantly less hepatic steatosis vs wild-type controls
View Research Applications
Research Applications
This mouse can be used to support research in many areas including:Dgat1tm1Far related
Cardiovascular Research
Hypotriglyceridemia
Developmental Biology Research
Skin and Hair Texture Defects
Diabetes and Obesity Research
Obesity With Diabetes (diet-induced, resistant)
Internal/Organ Research
Adipose Defects
Metabolism Research
Lipid Metabolism
| Allele Symbol | Dgat1tm1Far | ||
|---|---|---|---|
| Allele Name | targeted mutation 1, Bob Farese | ||
| Allele Type | Targeted (knock-out) | ||
| Mutation Made By | Bob Farese, Gladstone Inst of Cardiovascular Disease | ||
| Gene Symbol and Name | Dgat1, diacylglycerol O-acyltransferase 1 | ||
| Chromosome | 15 | ||
| Gene Common Name(s) | ARGP1; C75990; D15Ertd23e; DGAT; DNA segment, Chr 15, ERATO Doi 23, expressed; expressed sequence C75990; | ||
| Molecular Note | A genomic fragment containing sequences encoding the carboxy-terminus of the protein was replaced by a neomycin cassette. Northern blot analysis did not detect a full length transcript produced from this allele in homozygous mice. Tissue DGAT activity was absent ot severely reduced in homozygous mice. [MGI Ref ID J:61885] | ||
Genotyping Protocols
Dgat1tm1Far, HRM, vers. 4
Dgat1tm1Far, SEP PCR, vers. 3
Dgat1tm1Far, STD PCR, vers. 1
Dgat1tm1Far, STD PCR, vers. 2
Helpful Links
Optimizing PCR Protocols
Smith SJ; Cases S; Jensen DR; Chen HC; Sande E; Tow B; Sanan DA; Raber J; Eckel RH; Farese RV Jr. 2000. Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking Dgat [see comments] Nat Genet 25(1):87-90. [PubMed: 10802663] [MGI Ref ID J:61885]
Dgat1tm1Far relatedBuhman KK; Smith SJ; Stone SJ; Repa JJ; Wong JS; Knapp FF Jr; Burri BJ; Hamilton RL; Abumrad NA; Farese RV Jr. 2002. DGAT1 is not essential for intestinal triacylglycerol absorption or chylomicron synthesis. J Biol Chem 277(28):25474-9. [PubMed: 11959864] [MGI Ref ID J:120436]
Cases S; Zhou P; Shillingford JM; Wiseman BS; Fish JD; Angle CS; Hennighausen L; Werb Z; Farese RV Jr. 2004. Development of the mammary gland requires DGAT1 expression in stromal and epithelial tissues. Development 131(13):3047-55. [PubMed: 15163627] [MGI Ref ID J:128259]
Chen HC; Ladha Z; Farese RV Jr. 2002. Deficiency of acyl coenzyme a:diacylglycerol acyltransferase 1 increases leptin sensitivity in murine obesity models. Endocrinology 143(8):2893-8. [PubMed: 12130553] [MGI Ref ID J:78337]
Chen HC; Ladha Z; Smith SJ; Farese RV Jr. 2003. Analysis of energy expenditure at different ambient temperatures in mice lacking DGAT1. Am J Physiol Endocrinol Metab 284(1):E213-8. [PubMed: 12388146] [MGI Ref ID J:107764]
Chen HC; Rao M; Sajan MP; Standaert M; Kanoh Y; Miura A; Farese RV Jr; Farese RV. 2004. Role of adipocyte-derived factors in enhancing insulin signaling in skeletal muscle and white adipose tissue of mice lacking Acyl CoA:diacylglycerol acyltransferase 1. Diabetes 53(6):1445-51. [PubMed: 15161747] [MGI Ref ID J:90374]
Chen HC; Smith SJ; Ladha Z; Jensen DR; Ferreira LD; Pulawa LK; McGuire JG; Pitas RE; Eckel RH; Farese RV Jr. 2002. Increased insulin and leptin sensitivity in mice lacking acyl CoA:diacylglycerol acyltransferase 1. J Clin Invest 109(8):1049-55. [PubMed: 11956242] [MGI Ref ID J:76091]
Chen HC; Smith SJ; Tow B; Elias PM; Farese RV Jr. 2002. Leptin modulates the effects of acyl CoA:diacylglycerol acyltransferase deficiency on murine fur and sebaceous glands. J Clin Invest 109(2):175-81. [PubMed: 11805129] [MGI Ref ID J:74340]
Liu L; Zhang Y; Chen N; Shi X; Tsang B; Yu YH. 2007. Upregulation of myocellular DGAT1 augments triglyceride synthesis in skeletal muscle and protects against fat-induced insulin resistance. J Clin Invest 117(6):1679-89. [PubMed: 17510710] [MGI Ref ID J:122086]
Liu Y; Millar JS; Cromley DA; Graham M; Crooke R; Billheimer JT; Rader DJ. 2008. Knockdown of acyl-CoA:diacylglycerol acyltransferase 2 with antisense oligonucleotide reduces VLDL TG and ApoB secretion in mice. Biochim Biophys Acta 1781(3):97-104. [PubMed: 18252207] [MGI Ref ID J:133527]
Paglialunga S; Fisette A; Yan Y; Deshaies Y; Brouillette JF; Pekna M; Cianflone K. 2008. Acylation-stimulating protein deficiency and altered adipose tissue in alternative complement pathway knockout mice. Am J Physiol Endocrinol Metab 294(3):E521-9. [PubMed: 18160458] [MGI Ref ID J:133454]
Streeper RS; Koliwad SK; Villanueva CJ; Farese RV Jr. 2006. Effects of DGAT1 deficiency on energy and glucose metabolism are independent of adiponectin. Am J Physiol Endocrinol Metab 291(2):E388-94. [PubMed: 16595853] [MGI Ref ID J:111346]
Wongsiriroj N; Piantedosi R; Palczewski K; Goldberg IJ; Johnston TP; Li E; Blaner WS. 2008. The molecular basis of retinoid absorption: a genetic dissection. J Biol Chem 283(20):13510-9. [PubMed: 18348983] [MGI Ref ID J:137102]
Colony Maintenance
Breeding & Husbandry This strain originated on a B6;129S4 background and has been backcrossed to C57BL/6J for ten generations. If homozygous females are used for breeding, foster mothers are necessary, as homozygous females are unable to nurse. The donating investigator maintained this mutant strain by crossing homozygous males with heterozygous females. Coat color expected from breeding:Black Diet Information LabDiet® 5K52/5K67
| Pricing for USA, Canada and Mexico shipping destinations |
|
*Price(s) in US dollars ($)
Weeks of Age Price* Gender Cryorecovery Fee $1900.00 Cryopreserved Embryos Fee $1600.00
| Pricing for International shipping destinations |
|
*Price(s) in US dollars ($)
Weeks of Age Price* Gender Cryorecovery Fee $2470.00 Cryopreserved Embryos Fee $2080.00
| Standard Supply | Repository-Cryopreserved. Must Be Recovered. Please refer to pricing and supply notes for further information. |
|---|---|
| Supply Notes |
|
| Control | ||
|---|---|---|
| Wild-type from the colony | ||
| 000664 C57BL/6J | ||
| Considerations for Choosing Controls | ||
| USA, Canada and Mexico - Control Pricing Information for Genetically Engineered Mutant Strains. | ||
| International - Control Pricing Information for Genetically Engineered Mutant Strains. | ||
Purchasing Information
JAX® Mice Orders
Surgical Services
Contact Information
Orders & Technical Support
Tel: 800.422.6423 or 207.288.5845
Fax: 207.288.6150
Technical Support Email Form
For Licensing and Use Restrictions view the link(s) below:
- Use of MICE by companies or for-profit entities requires a license prior to shipping.
| phone: | 207-288-6470 |
| fax: | 207-288-6655 |
MICE, PRODUCTS AND SERVICES ARE PROVIDED “AS IS”. THE LABORATORY EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.
In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of MICE, products or services, The Jackson Laboratory will, at its option, provide credit or replacement for the MICE or product received or the services provided.
In no event shall The Jackson Laboratory, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, products or services, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of The Jackson Laboratory, its agents or employees. In purchasing or receiving MICE, products or services from The Jackson Laboratory, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges The Jackson Laboratory from all such causes of action or damages, and further agrees to defend and indemnify The Jackson Laboratory from any costs or damages arising out of any third party claims.
MICE and biological materials are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.
The foregoing represents the General Terms and Conditions applicable to The Jackson Laboratory’s MICE, products and services. In addition, special terms and conditions of sale of certain MICE, products and services may be set forth separately in The Jackson Laboratory web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, products and services by The Jackson Laboratory, and by its licensees and distributors.
Acceptance of delivery of MICE, products or services shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on The Jackson Laboratory, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, products services by The Jackson Laboratory.